{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
m cidofovir
to a specific field?
Status:
Investigational
Source:
INN:efdoralprin alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04631016: Phase 2 Interventional Completed Chronic Obstructive Pulmonary Disease (COPD)
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03976401: Phase 2 Interventional Completed NASH - Nonalcoholic Steatohepatitis
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:efbalropendekin alfa [INN]
Source URL:
Class:
PROTEIN
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT03654508: Not Applicable Interventional Completed Asthma in Children
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01342263: Not Applicable Interventional Completed Ischemic Heart Disease
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00471120: Not Applicable Interventional Terminated Uterine Cancer
(2006)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tamrintamab pamozirine [INN]
Source URL:
Class:
PROTEIN
